
Masimo Corporation MASI
Quarterly report 2026-Q1
added 05-05-2026
Masimo Corporation ROE Ratio 2011-2026 | MASI
Annual ROE Ratio Masimo Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -28.99 | 5.97 | 10.72 | 17.07 | - | 16.8 | 19.97 | 17.24 | 30.25 | 23.7 | - | 17.89 | 22.81 | 32.29 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 32.29 | -28.99 | 15.48 |
Quarterly ROE Ratio Masimo Corporation
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12.63 | -25.51 | -24.84 | -11.78 | -15.53 | 3.22 | 4.42 | 4.95 | 5.39 | 7.9 | 9.4 | 9.71 | 11.05 | 9.47 | 13.41 | 15.51 | 16.58 | 15.06 | 14.61 | 15.15 | 12.78 | 17.31 | 18.03 | 17.72 | 16.8 | 17.11 | 18.8 | 19.49 | 19.97 | 14.06 | 13.12 | 14.83 | 17.24 | 56.73 | 56.74 | 55.86 | 53.67 | 6950.23 | 6952.45 | 6953.91 | 6955.33 | 25.59 | 23.67 | 4336.91 | 10724.09 | 10726.94 | 10726.47 | 6411.62 | 17.88 | 20.53 | 20.8 | 22.06 | 22.8 | 22.3 | 22.61 | 22.28 | 23.01 | 5.36 | 6.15 | 6.51 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10726.94 | -25.51 | 1191.76 |
ROE Ratio of other stocks in the Medical instruments industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
4.55 | $ 60.38 | 1.53 % | $ 12 B | ||
|
Atrion Corporation
ATRI
|
7991.72 | - | - | $ 810 M | ||
|
iRhythm Technologies
IRTC
|
-29.17 | - | - | $ 3.65 B | ||
|
Intuitive Surgical
ISRG
|
16.02 | - | - | $ 153 B | ||
|
Luminex Corporation
LMNX
|
2.93 | - | - | $ 1.75 B | ||
|
ICU Medical
ICUI
|
0.03 | $ 122.99 | 0.78 % | $ 3.03 B | ||
|
Repro Med Systems
KRMD
|
-15.47 | $ 3.98 | 3.38 % | $ 184 M | ||
|
Akers Biosciences, Inc.
AKER
|
-50.84 | - | -9.52 % | $ 20.6 M | ||
|
LeMaitre Vascular
LMAT
|
14.66 | - | - | $ 2.25 B | ||
|
Alcon
ALC
|
-2.82 | $ 64.0 | 0.88 % | $ 40.4 B | ||
|
Antares Pharma, Inc.
ATRS
|
47.18 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
1.88 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
-23.1 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
12.92 | - | -0.05 % | $ 10.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
-129.56 | - | - | $ 28.6 M | ||
|
Envista Holdings Corporation
NVST
|
1.51 | $ 23.86 | -0.25 % | $ 4.01 B | ||
|
Varian Medical Systems, Inc.
VAR
|
16.51 | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
817.2 | $ 6.43 | 1.74 % | $ 54.5 K | ||
|
STERIS plc
STE
|
9.31 | $ 215.98 | 2.31 % | $ 21.3 B | ||
|
Haemonetics Corporation
HAE
|
20.43 | $ 57.12 | 0.19 % | $ 2.87 B | ||
|
Teleflex Incorporated
TFX
|
-28.98 | $ 130.28 | 0.18 % | $ 5.81 B | ||
|
STAAR Surgical Company
STAA
|
-23.37 | $ 32.01 | 8.88 % | $ 1.59 B | ||
|
Isoray
ISR
|
-49.81 | - | 0.03 % | $ 108 M | ||
|
Glaukos Corporation
GKOS
|
-29.16 | $ 142.15 | 3.54 % | $ 6.88 B | ||
|
InfuSystem Holdings
INFU
|
11.56 | $ 8.61 | 4.87 % | $ 178 M | ||
|
Microbot Medical
MBOT
|
-16.95 | $ 1.85 | -14.75 % | $ 84.7 M | ||
|
Milestone Scientific
MLSS
|
-203.45 | $ 0.34 | -5.04 % | $ 27.9 M | ||
|
Merit Medical Systems
MMSI
|
8.11 | $ 62.56 | -0.1 % | $ 3.7 B | ||
|
Utah Medical Products
UTMD
|
2.15 | $ 63.7 | -0.55 % | $ 206 M | ||
|
West Pharmaceutical Services
WST
|
15.54 | $ 300.19 | -0.73 % | $ 21.7 B | ||
|
Pulse Biosciences
PLSE
|
-90.24 | $ 27.1 | 13.11 % | $ 1.83 B | ||
|
DENTSPLY SIRONA
XRAY
|
-44.66 | $ 10.41 | -0.29 % | $ 2.08 B | ||
|
Retractable Technologies
RVP
|
-16.89 | $ 0.69 | -1.42 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
24.51 | $ 58.65 | 2.11 % | $ 193 M | ||
|
Predictive Oncology
POAI
|
-488.5 | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
-1.24 | $ 21.06 | -0.52 % | $ 1.01 B | ||
|
Stereotaxis
STXS
|
-160.54 | - | - | $ 176 M | ||
|
Baxter International
BAX
|
-15.61 | $ 17.78 | 2.72 % | $ 9.12 B | ||
|
ResMed
RMD
|
23.19 | $ 202.46 | 0.34 % | $ 29.6 B | ||
|
AtriCure
ATRC
|
-2.33 | $ 28.15 | 5.87 % | $ 1.34 B | ||
|
Harvard Bioscience
HBIO
|
-412.84 | $ 5.52 | -0.81 % | $ 245 M | ||
|
NeuroMetrix
NURO
|
-54.54 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
-18.58 | $ 11.03 | 1.75 % | $ 451 M | ||
|
Becton, Dickinson and Company
BDX
|
6.61 | - | - | $ 41.6 B | ||
|
Nephros
NEPH
|
11.7 | $ 3.34 | -5.92 % | $ 35.4 M | ||
|
OraSure Technologies
OSUR
|
-20.17 | $ 2.95 | -2.96 % | $ 217 M | ||
|
Repligen Corporation
RGEN
|
2.32 | $ 103.38 | -3.41 % | $ 5.81 M |